aTyr Pharma Reports Publication on ATYR0101 Anti-Fibrotic Effects
The company says ATYR0101 is undergoing IND-enabling studies and expects to advance it into clinical testing in 2027.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.